4-trifluoromethyl-2,6-dimethylpyrimidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-trifluoromethyl-2,6-dimethylpyrimidine
• 英文别名: 2,4-Dimethyl-6-(trifluoromethyl)pyrimidine
• 化学式: C₇H₇F₃N₂
• 分子量: 176.141
• InChiKey: AVDYROAQRHTYDK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  盐酸乙脒 、 1,1,1-三氟-4-甲氧基-3-戊烯-2-酮 在 sodium methylate 作用下， 反应 2.5h， 以68%的产率得到4-trifluoromethyl-2,6-dimethylpyrimidine
  参考文献：
  名称：

  卤代乙酰化的烯醇醚。9。4-三氟甲基-2-甲基[苯基]嘧啶和四氢衍生物的合成

  摘要：

  据报道由β-烷氧基乙烯基三氟甲基酮1a-d与乙am或苯甲hydro盐酸盐的环缩合反应合成4-三氟甲基-2-甲基[苯基]嘧啶和相应的四氢衍生物。对于1a-d与乙am和盐酸苄am的环缩合，测试了两种方法：1 M氢氧化钠溶液（方法A）和醇钠/醇溶液（方法B）。根据β-烷氧基乙烯基三氟甲基酮的结构和反应条件，获得嘧啶或四氢嘧啶或两种化合物的混合物。

  DOI：

  10.1002/jhet.5570350231

文献信息

• [EN] AZOLINE COMPOUNDS<br/>[FR] COMPOSÉS AZOLINE
  申请人：BASF SE

  公开号：WO2015128358A1

  公开（公告）日：2015-09-03

  The present invention relates to azoline compounds of formula (I) wherein A, B1, B2, B3, G1, G2, X1, R1, R3a, R3b, Rg1 and Rg2 are as defined in the claims and the description. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及式（I）的噁唑啉化合物，其中A、B1、B2、B3、G1、G2、X1、R1、R3a、R3b、Rg1和Rg2如权利要求和描述中所定义。这些化合物对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫方面具有用途。该发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法，以及包括所述化合物的植物繁殖材料、农业和兽医组合物。
• SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
  申请人：GLAXOSMITHKLINE LLC

  公开号：US20150152108A1

  公开（公告）日：2015-06-04

  The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本发明涉及新型取代桥式脲化合物，相应的相关类似物，药物组合物以及其使用方法。本发明的抑制素调节化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和疾病，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块疾病、炎症、癌症和/或潮红有关的疾病或疾病，以及那些会受益于增加线粒体活性的疾病或疾病。本发明还涉及包含抑制素调节化合物与另一治疗剂组合的组合物。
• [EN] THIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND THEIR USE AS TYK2 KINASE INHIBITORS<br/>[FR] COMPOSÉS DE THIAZOLOPYRIDINE, COMPOSITIONS ET LEUR UTILISATION COMME INHIBITEURS DE LA KINASE TYK2
  申请人：HOFFMANN LA ROCHE

  公开号：WO2015091584A1

  公开（公告）日：2015-06-25

  Provided are thiazolopyridine compounds that are inhibitors of TYK2 kinase, compositions containing these compounds and methods for treating diseases mediated by TYK2 kinase. In particular, provided are compounds of Formula (I), (II) or (III), stereoisomers, tautomers, solvates, prodrugs or pharmaceutically acceptable salts thereof, where X, R0, R1, R2, R3, R4 and R5 are defined herein, pharmaceutical compositions comprising the compound and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, for example, for treating a disease or condition mediated by TYK2 kinase in a patient.

  提供了一些噻唑吡啶化合物，这些化合物是TYK2激酶的抑制剂，包含这些化合物的组合物以及治疗由TYK2激酶介导的疾病的方法。具体来说，提供了符合Formula (I)、(II)或(III)的化合物，其立体异构体、互变异构体、溶剂合物、前药或其药用可接受的盐，其中X、R0、R1、R2、R3、R4和R5在此有定义，包括该化合物和药用可接受的载体、辅料或溶剂的药物组合物，使用该化合物或组合物进行治疗的方法，例如，用于治疗患有TYK2激酶介导的疾病或症状的患者。
• FURANYL COMPOUNDS AND THE USE THEREOF
  申请人：NovoMedix, LLC

  公开号：US20140309297A1

  公开（公告）日：2014-10-16

  Provided herein are substituted furanyl compounds, pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or amelioration of various disorders, including cancer and proliferative disorders. In one embodiment, the compounds provided herein modulate eIF4E activity. In one embodiment, the compounds provided herein modulate the Hedgehog pathway activity. In one embodiment, the compounds provided herein are used in combination with surgery, radiation therapy, immuno therapy and/or one or more additional anticancer drugs for the treatment, prevention, and/or amelioration of cancer and proliferative disorders.

  本文提供了替代呋喃基化合物，包括这些化合物的制药组合物、制备方法和使用方法。这些化合物对于治疗、预防和/或改善各种疾病，包括癌症和增殖性疾病，具有用途。在一个实施例中，本文提供的化合物调节eIF4E活性。在一个实施例中，本文提供的化合物调节Hedgehog通路活性。在一个实施例中，本文提供的化合物与手术、放射治疗、免疫治疗和/或一个或多个其他抗癌药物结合使用，用于治疗、预防和/或改善癌症和增殖性疾病。
• C-H FLUORINATION OF HETEROCYCLES WITH SILVER (II) FLUORIDE
  申请人：THR REGENTS OF THE UNIVERSITY OF CALIFORNIA

  公开号：US20160185723A1

  公开（公告）日：2016-06-30

  The present invention provides compositions and methods for the selective C—H fluorination of nitrogen-containing heteroarenes with AgF 2 , which has previously been considered too reactive for practical, selective C—H fluorination. Fluorinated heteroarenes are prevalent in numerous pharmaceuticals, agrochemicals and materials. However, the reactions used to introduce fluorine into these molecules require pre-functionalized substrates or the use of F 2 gas. The present invention provides a mild and general method for the C—H fluorination of nitrogen-containing heteroarene compounds to 2-fluoro-heteroarenes with commercially available AgF 2 . In various embodiments, these reactions occur at ambient temperature within one hour and occur with exclusive selectivity for fluorination at the 2-position. Exemplary reaction conditions are effective for fluorinating diazine heteroarenes to form a single fluorinated isomer.

  本发明提供了使用AgF2对含氮杂环进行选择性C-H氟化的组合物和方法，这在以前被认为过于反应活泼而不适用于实际的选择性C-H氟化。氟代杂环在许多药物、农药和材料中广泛存在。然而，用于将氟引入这些分子的反应需要预功能化的底物或使用F2气体。本发明提供了一种轻柔且通用的方法，用于使用商业上可获得的AgF2对含氮杂环化合物进行C-H氟化，以形成2-氟杂环。在各种实施例中，这些反应在一个小时内在室温下发生，并且仅在2位进行氟化的选择性非常高。示例反应条件对于氟化二氮杂环以形成单个氟代异构体是有效的。